日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议

Armstrong, Andrew J; Morris, Michael J; Abida, Wassim; Aggarwal, Rahul R; Antonarakis, Emmanuel S; Attard, Gerhardt; Beltran, Himisha; Bryce, Alan; Carducci, Michael A; Cheng, Heather H; Chen, Delphine L; Chi, Kim N; Childs, Daniel S; Dahut, William; Emmett, Louise; Fizazi, Karim; Gafita, Andrei; George, Daniel J; Hermann, Ken; Hofman, Michael S; Hope, Thomas; Hussain, Maha; Kelly, W Kevin; Kessler, Elizabeth; Kuo, Phillip H; Lang, Joshua; Liu, Glenn; Marshall, Catherine H; Morgans, Alicia K; McKay, Rana R; Nanus, David; Nelson, Peter; Paller, Channing; Reichert, Zachery R; Ryan, Charles J; Sartor, A Oliver; Schöder, Heiko; Schwartz, Lawrence H; Sharifi, Nima; Stadler, Walter M; Stein, Mark; Sternberg, Cora N; Szmulewitz, Russell Z; Tagawa, Scott T; Sokolova, Alexandra O; Wyatt, Alex W; Yamoah, Kosj; Yu, Evan Y; Halabi, Susan; Scher, Howard I

Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel

前列腺癌治疗策略的演变:来自“弥合前列腺癌治疗差距”专家组的新兴方法和未满足的需求

McKay, Rana R; Maughan, Benjamin L; Morgans, Alicia K; Shore, Neal D; Yu, Evan Y; Madan, Ravi A; Berchuck, Jacob E; Carthon, Bradley C; Finkelstein, Steven E; Gomella, Leonard; Gorin, Michael A; Hahn, Andrew W; Loeb, Stacy; Narayan, Vivek K; Petrylak, Daniel P; Ryan, Charles J; Tawagi, Karine; Tran, Phuoc T; Dorff, Tanya

Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer

循环肿瘤DNA中的致病性基因组改变可预测转移性去势抵抗性前列腺癌患者的总生存期

Halabi, Susan; Guo, Siyuan; Luo, Bin; Yu, Chenxi; Knutson, Todd P; Kobilka, Anna; Lyman, Jacqueline; Beltran, Himisha; Antonarakis, Emmanuel S; Galsky, Matthew D; Rosenberg, Jonathan E; Ryan, Charles J; Small, Eric J; Kelly, W Kevin; Morris, Michael J; Page, David; Dehm, Scott M; Armstrong, Andrew J

Feasibility and Implementation of INTERVAL-GAP4: A Global Randomised Controlled Trial of Intense Hybrid-supervised/Self-managed Versus Self-directed Exercise for Metastatic Prostate Cancer

INTERVAL-GAP4 的可行性及实施:一项针对转移性前列腺癌患者的强化混合式监督/自我管理运动与自主运动的全球随机对照试验

Kenfield, Stacey A; Hart, Nicolas H; Courneya, Kerry S; Greenwood, Rosemary; Chan, June M; Sison, Jennette; Zhang, Li; Rudman, Sarah; Ung, Leah; Schumann, Moritz; Van Blarigan, Erin L; McKeown, Sam; Ryan, Charles J; Catto, James; Galvão, Daniel A; Newton, Robert U; Saad, Fred

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

前列腺癌患者生活质量的遗传驱动因素:E3805 CHAARTED 试验中遗传多态性和患者报告结局的评估

Sentana-Lledo, Daniel; Chu, Xiangying; Ryan, Charles J; Gupta, Arjun; Sweeney, Christopher J; Jarrard, David F; Plimack, Elizabeth R; Gartrell, Benjamin A; Carducci, Michael A; Hussain, Maha; Garcia, Jorge A; Cella, David; DiPaola, Robert S; Pomerantz, Mark; Morgans, Alicia K

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.

转录组分析揭示了致命性前列腺癌中恩扎卢胺极度无反应的机制

Kumaraswamy Anbarasu, Hu Ya-Mei, Yates Joel A, Zhang Chao, Rodansky Eva, Khokhani Dhruv, Flores Diana, Duan Zhi, Zhang Yi, Tabatabaei Shaadi, Slottke Rachel, Ye Shangyuan, Lara Primo, Foye Adam, Ryan Charles J, Quigley David A, Huang Jiaoti, Aggarwal Rahul, Reiter Robert E, Wicha Max S, Beer Tomasz M, Rettig Matthew, Gleave Martin, Evans Christopher P, Witte Owen N, Stuart Joshua M, Thomas George V, Feng Felix Y, Small Eric J, Xia Zheng, Alumkal Joshi J

Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024

针对生化复发和晚期前列腺癌患者实施循证策略:2024 年美国前列腺癌大会共识建议

Bryce, Alan H; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S; Armstrong, Andrew J; Calais, Jeremie; Carducci, Michael A; Dorff, Tanya Barauskas; Efstathiou, Jason A; Gleave, Martin; Gomella, Leonard G; Higano, Celestia; Hope, Thomas A; Iagaru, Andrei; Morgans, Alicia K; Morris, David S; Morris, Michael J; Petrylak, Daniel P; Reiter, Robert E; Rettig, Matthew B; Ryan, Charles J; Sellinger, Scott B; Spratt, Daniel E; Srinivas, Sandy; Tagawa, Scott T; Taplin, Mary-Ellen; Yu, Evan Y; Zhang, Tian; McKay, Rana R; Koo, Phillip J; Crawford, E David

HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers

HSD3B1 (c.1100C) 基因型与乳腺癌和子宫内膜癌的不同肿瘤和临床结果相关

Vobugari, Nikitha; Makovec, Allison; Kellen, Samuel; Nazari, Shayan S; Elliott, Andrew; Schmeck, Devin; Deacon, Aiden; von Dohlen, Gabriella; John, Emily; Barata, Pedro C; Agarwal, Neeraj; Geller, Melissa A; Erickson, Britt K; Sledge, George; Ostrander, Julie H; McKay, Rana R; Ryan, Charles J; Sharifi, Nima; Antonarakis, Emmanuel S; Hwang, Justin

The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer

种系 HSD3B1 肾上腺许可等位基因 (c.1100 C) 对前列腺癌体细胞突变图谱、转录组和免疫细胞浸润的影响

Kellen, Samuel; Makovec, Allison; Miller, Carly D; Nazari, Shayan S; Elliott, Andrew; Deacon, Aiden; John, Emily; Vobugari, Nikitha; Agarwal, Neeraj; McKay, Rana R; Barata, Pedro C; Ryan, Charles J; Sharifi, Nima; Hwang, Justin; Antonarakis, Emmanuel S

Expression Patterns of DLL3 across Neuroendocrine and Non-neuroendocrine Neoplasms Reveal Broad Opportunities for Therapeutic Targeting

DLL3在神经内分泌肿瘤和非神经内分泌肿瘤中的表达模式揭示了广泛的治疗靶向机会

Lozada, John R; Elliott, Andrew; Evans, Mark G; Wacker, James; Storey, Kathleen M; Egusa, Emily A; Zorko, Nicholas A; Kumar, Akhilesh; Crymes, Anthony; Heath, Elisabeth I; Carneiro, Benedito A; Soares, Heloisa P; Cichocki, Frank; Miller, Jeffrey S; Lou, Emil; Beltran, Himisha; Antonarakis, Emmanuel S; Ryan, Charles J; Hwang, Justin H